» Articles » PMID: 9673834

Pharmacokinetic and Pharmacodynamic Changes in the Elderly. Clinical Implications

Overview
Specialty Pharmacology
Date 1998 Jul 23
PMID 9673834
Citations 66
Authors
Affiliations
Soon will be listed here.
Abstract

Age-related changes in pharmacokinetics principally affect drug absorption, distribution, metabolism and elimination. Changes in pharmacodynamics are primarily seen in the cardiovascular and neuroendocrine system. Age-dependent changes in the kinetics and dynamics of drugs acting on the cardiovascular system and central nervous system are common, and this review, while by no means exhaustive of the effects of drugs on all organ systems, is reflective of the principles and gives examples of the effects of age on these 2 major systems. While pharmacokinetic changes in the elderly are usually well characterised, pharmacodynamic changes are understood only in the most preliminary way. There has been relatively little research in this area of geriatric clinical pharmacology, and pharmacodynamic changes are still an area of investigation.

Citing Articles

Clinical pearls for the management of duloxetine patients with medical comorbidities.

OConnell M, VandenBerg A Ment Health Clin. 2024; 14(6):313-320.

PMID: 39703684 PMC: 11616965. DOI: 10.9740/mhc.2024.12.313.


Anthracyclines-Induced Cardiac Dysfunction: What Every Clinician Should Know.

Ferrera A, Fiorentini V, Reale S, Solfanelli G, Tini G, Barbato E Rev Cardiovasc Med. 2024; 24(5):148.

PMID: 39076747 PMC: 11273047. DOI: 10.31083/j.rcm2405148.


Age-related modifications in CYP-dependent drug metabolism: role of stress.

Konstandi M, Johnson E Front Endocrinol (Lausanne). 2023; 14:1143835.

PMID: 37293497 PMC: 10244505. DOI: 10.3389/fendo.2023.1143835.


Reassessment of Treatments in a Long-Term Care Unit.

Ladjouzi N, Romdhani A, Zouloumis G, Ould Ouali C, Jhouri A, Schlatter J Gerontol Geriatr Med. 2023; 9:23337214231156030.

PMID: 36819230 PMC: 9932759. DOI: 10.1177/23337214231156030.


The association between benzodiazepine use and greater risk of neurocognitive impairment is moderated by medical burden in people with HIV.

Sundermann E, Saloner R, Rubtsova A, Nguyen A, Letendre S, Moore R J Neurovirol. 2022; 28(3):410-421.

PMID: 35389174 PMC: 9470605. DOI: 10.1007/s13365-022-01076-1.


References
1.
Weidmann P, Maxwell M, de LIMA J . Effect on aging on plasma renin and aldosterone in normal man. Kidney Int. 1975; 8(5):325-33. DOI: 10.1038/ki.1975.120. View

2.
BENDER A . THE EFFECT OF INCREASING AGE ON THE DISTRIBUTION OF PERIPHERAL BLOOD FLOW IN MAN. J Am Geriatr Soc. 1965; 13:192-8. DOI: 10.1111/j.1532-5415.1965.tb02665.x. View

3.
Buhler F, Hulthen U, Kiowski W, Muller F, Bolli P . The place of the calcium antagonist verapamil in antihypertensive therapy. J Cardiovasc Pharmacol. 1982; 4 Suppl 3:S350-7. View

4.
Ciabattoni G, Cinotti G, Pierucci A, Simonetti B, Manzi M, Pugliese F . Effects of sulindac and ibuprofen in patients with chronic glomerular disease. Evidence for the dependence of renal function on prostacyclin. N Engl J Med. 1984; 310(5):279-83. DOI: 10.1056/NEJM198402023100502. View

5.
BENDER A . PHARMACOLOGIC ASPECTS OF AGING: A SURVEY OF THE EFFECT OF INCREASING AGE ON DRUG ACTIVITY IN ADULTS. J Am Geriatr Soc. 1964; 12:114-34. DOI: 10.1111/j.1532-5415.1964.tb00344.x. View